Table 6.
Rank | Molecules | Counts | Pathological process | Counts | Diseases | Counts |
---|---|---|---|---|---|---|
1 | MLKL | 521 | Cell-death | 1,211 | Cancer | 170 |
2 | TNF-alpha | 358 | Apoptosis | 1,104 | Ischemia/reperfusion injury | 110 |
3 | NF-κB | 315 | Necroptosis | 885 | Infection | 50 |
4 | RIPK3 | 233 | Necrosis | 557 | Carcinoma | 32 |
5 | RIPK1 | 155 | Inflammation | 443 | Alzheimer’s disease | 31 |
6 | Complex | 89 | Oxidative stress | 273 | Brain injury | 30 |
7 | Caspase-8 | 82 | Phosphorylation | 254 | Fibrosis | 26 |
8 | NLRP3 | 65 | Autophagy | 204 | Stroke | 26 |
9 | ROS | 50 | Proliferation | 70 | Acute kidney injury | 25 |
10 | FADD | 38 | ER stress | 65 | Breast cancer | 25 |
11 | Necrostatin-1 | 37 | Ubiquitination | 45 | Tumor | 23 |
12 | Inflammasome | 34 | DNA damage | 40 | Drug resistance | 22 |
13 | p53 | 33 | Pyroptosis | 26 | Hepatocellular carcinoma | 22 |
14 | bcl-2 | 32 | Ferroptosis | 25 | Inflammatory bowel disease | 20 |
15 | Toll-like receptors | 19 | Mitophagy | 19 | Parkinson’s disease | 19 |
MLKL, mixed lineage kinase domain-like protein; TNF-alpha, tumor necrosis factor-alpha; NF-κB, nuclear factor κ-light-chain-enhancer of activated B cells; RIPK3, receptor-interacting protein kinase-3; RIPK1, receptor-interacting protein kinase-1; NLRP3, NOD-, LRR- and pyrin domain-containing protein 3; ROS, reactive oxygen species; FADD, Fas-associated via death domain; er stress, endoplasmic reticulum stress; bcl-2, B-cell lymphoma-2.